Beijing Registers 365 New HIV Carriers, AIDS Patients
Posted on: Thursday, 1 September 2005, 09:01 CDT
Beijing registers 365 new HIV carriers, AIDS patients
BEIJING, Aug. 31 (Xinhua) -- Beijing found 365 new HIV carriers and AIDS patients in the first seven months of the year, making the total number 2,515 by the end of July in the Chinese capital, a senior health official said Wednesday.
The newly registered cases include 311 HIV carriers and 54 AIDS patients, up 53.2 percent and 42.1 percent, respectively, over the corresponding period last year, according to Liang Wannian, deputy head with the Beijing Municipal Sanitary Department.
Among all the HIV carriers in Beijing, 486 are local citizens and 119 are foreigners.
Intravenous drug-use and unsafe sex are the two major channels of HIV transmission among Chinese, according to the official.
About 50 AIDS patients have received free treatment in two specially designated hospitals so far.
To curb the spread of the killer disease, the municipal government began offering free consultations and tests on the HIV virus in August last year.
In addition, Beijing has publicly promoted the use of condoms and launched a clean needle exchange project.
Official statistics show that among China's 840,000 people living with HIV/AIDS, 45 percent get infected through drug injection, 25 percent through blood transfusions and 30 percent through unsafe sex.
Source: Xinhua News Agency - CEIS
Related Articles
- Video: 'Project Runway' Designer Launches New Online Video Series to Educate About Living with HIV and AIDS and Help Combat HIV Stigma
- Anglo American's Coal Division in South Africa Wins Global Business Coalition Award for top International Workplace HIV and AIDS Programme
- Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market
- AstraZeneca's Recentin Plus FOLFOX4 to Earn 10 Percent Patient Share in the Treatment of Colorectal Cancer By 2016
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- Teva Pharmaceutical's Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis
- Research and Markets: Oxford Handbook Of Genitourinary Medicine, HIV And AIDS Out Now!
- Discovery Health Partners With Kenneth Cole and amfAR to Raise Awareness About HIV and AIDS on World AIDS Day
 |
 |
User Comments (0)
RSS Feeds